The change of prostate cancer treatment in Korea: 5 year analysis of a single institution

Yonsei Medical Journal

Volumn 54, Issue 1, 2013, Pages 87-91

  Lee, Dong Hoon ^a   Jung, Ha Bum ^a   Chung, Mun Su ^a   Lee, Seung Hwan ^a   Chung, Byung Ha ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Prostate cancer; Radical prostatectomy; Robotics; Therapeutics

Indexed keywords

CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; DATA BASE; FOLLOW UP; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROSTATE CANCER; PROSTATECTOMY; REVIEW; FACTUAL DATABASE; PROCEDURES; PROSTATIC NEOPLASMS; ROBOTICS; SOUTH KOREA; TIME; TREATMENT OUTCOME; TRENDS;

HORMONE;

DATABASES, FACTUAL; FOLLOW-UP STUDIES; HORMONES; HUMANS; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPUBLIC OF KOREA; ROBOTICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84871288953     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2013.54.1.87     Document Type: Review

References (18)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64, 1.
2. Sim HG, Cheng CW. Changing demography of prostate cancer in Asia. Eur J Cancer 2005;41:834-45.
3. Statistics Korea. [http://kostat.go.kr/portal/english/index.action].
4. Jung KW, Park S, Kong HJ, Won YJ, Boo YK, Shin HR, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci 2010;25:1113-21.
5. Park SK, Sakoda LC, Kang D, Chokkalingam AP, Lee E, Shin HR, et al. Rising prostate cancer rates in South Korea. Prostate 2006;66:1285-91.
6. Dasgupta P, Kirby RS. The current status of robot-assisted radical prostatectomy. Asian J Androl 2009;11:90-3.
7. Sung ER, Jeong W, Park SY, Ham WS, Choi YD, Hong SJ, et al. The "halo effect" in Korea: change in practice patterns since the introduction of robot-assisted laparoscopic radical prostatectomy. J Robotic Surg 2009;3:57-60.
8. National Evidence-based healthcare collaborating Agency (NECA), Korea. [http://www.neca.re.kr/eng].
9. Korea Ministry of Health and Welfare. National health insurance system. [http://english.mw.go.kr/front_eng/index.jSP].
10. Akaza H, Hinotsu S, Usami M, Ogawa O, Kagawa S, Kitamura T, et al. The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE. J Urol 2006;176(6 Pt 2):S47-9.
11. Hamilton AS, Albertsen PC, Johnson TK, Hoffman R, Morrell D, Deapen D, et al. Trends in the treatment of localized prostate cancer using supplemented cancer registry data. BJU Int 2011;107: 576-84.
12. McVey GP, McPhail S, Fowler S, McIntosh G, Gillatt D, Parker CC. Initial management of low-risk localized prostate cancer in the UK: analysis of the British Association of Urological Surgeons Cancer Registry. BJU Int 2010;106:1161-4.
13. Akaza H. Trends in primary androgen depletion therapy for patients with localized and locally advanced prostate cancer: Japanese perspective. Cancer Sci 2006;97:243-7.
14. Hinotsu S, Akaza H, Usami M, Ogawa O, Kagawa S, Kitamura T, et al. Current status of endocrine therapy for prostate cancer in Japan analysis of primary androgen deprivation therapy on the basis of data collected by J-CaP. Jpn J Clin Oncol 2007;37:775-81.
15. National Comprehensive Cancer Network® (NCCN). NCCN clinical practice guidelines in oncology: Asia consensus statement: prostate cancer. [http://www.nccn.org/professionals/physician_gls/PDF/prostate-asia.pdf].
16. Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010;28:1117-23.
17. Lubeck DP, Litwin MS, Henning JM, Stier DM, Mazonson P, Fisk R, et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1996;48:773-7.
18. Akaza H, Usami M, Hinotsu S, Ogawa O, Kagawa S, Kitamura T, et al. Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance. Jpn J Clin Oncol 2004;34:329-36.